Risks and medication errors analysis to evaluate the impact of a chemotherapy compounding workflow management system on cancer patients' safety.
Marzal-Alfaro MB, Rodriguez-Gonzalez CG, Escudero-Vilaplana V, et al. Risks and medication errors analysis to evaluate the impact of a chemotherapy compounding workflow management system on cancer patients’ safety. Health Informatics J. 2020;26(3):1995-2010. doi:10.1177/1460458219895434.
This study applied failure mode, effect, and criticality analysis (FMECA) methodology to identify the impact of an image-based workflow software on reducing chemotherapy errors. After software implementation, the overall medication error rate decreased significantly, as did all types of errors except wrong medicinal product errors.